Browsing by Author Briasoulis, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 123 to 126 of 126 < previous 
TitleAuthor(s)Issue date???itemlist.???
Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumabKoutras, A. K.; Antonacopoulou, A. G.; Eleftheraki, A. G.; Dimitrakopoulos, F. I.; Koumarianou, A.; Varthalitis, I.; Fostira, F.; Sgouros, J.; Briasoulis, E.; Bournakis, E.; Bafaloukos, D.; Bompolaki, I.; Galani, E.; Kalogeras, K. T.; Pectasides, D.; Fountzilas, G.; Kalofonos, H. P.24-Nov-2015-
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology GroupGogas, H.; Bafaloukos, D.; Aravantinos, G.; Fountzilas, G.; Tsoutsos, D.; Panagiotou, P.; Frangia, K.; Kalofonos, H. P.; Briasoulis, E.; Castana, O.; Polyzos, A.; Pectasides, D.; Ioannovich, J.24-Nov-2015-
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administrationBriasoulis, E.; Karavasilis, V.; Anastasopoulos, D.; Tzamakou, E.; Fountzilas, G.; Rammou, D.; Kostadima, V.; Pavlidis, N.24-Nov-2015-
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumorsBriasoulis, E.; Pentheroudakis, G.; Karavasilis, V.; Tzamakou, E.; Rammou, D.; Pavlidis, N.24-Nov-2015-